Epidemiology of Homocysteine as a Risk Factor in Diabetes
Authors:
- 1 June 2003
- journal article
- review article
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 1 (2) , 105-120
Abstract
Patients with diabetes mellitus are prone to cardiovascular disease, and risk factors presumably unrelated to diabetes, such as hyperhomocysteinemia, may be involved in the atherothrombotic process in these subjects. Plasma homocysteine levels are usually normal in diabetes, although both lower and higher levels have been reported. This has been ascribed to hyperfiltration and renal dysfunction or low folate status, respectively. Insulin resistance does not appear to be a major determinant of plasma homocysteine level. Hyperhomocysteinemia has been associated with microalbuminuria and retinopathy in type 1 and type 2 diabetes. In patients with type 2 diabetes, plasma homocysteine concentration has also been shown to be related to macrovascular disease and death. This relation seems to be stronger in subjects with diabetes than without. The underlying pathophysiological mechanism of this increased vascular risk remains unexplained, but may relate to worsening of endothelial dysfunction or structural vessel properties. Because homocysteine and diabetes have an apparent synergistic detrimental vascular effect, patients with diabetes are good candidates for screening and treatment with folic acid until the results of ongoing clinical trials are available.Keywords
This publication has 97 references indexed in Scilit:
- Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitusEuropean Journal of Clinical Investigation, 2002
- Global and societal implications of the diabetes epidemicNature, 2001
- The Relationship Among Homocysteine, Creatinine Clearance, and Albuminuria in Patients With Type 2 DiabetesDiabetes Care, 2001
- Hyperhomocysteinemia, Vascular Pathology, and Endothelial DysfunctionSeminars in Thrombosis and Hemostasis, 2000
- Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitusKidney International, 1999
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.Diabetes Care, 1999
- Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitusScandinavian Journal of Clinical and Laboratory Investigation, 1994
- Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatmentAtherosclerosis, 1993
- Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitusScandinavian Journal of Clinical and Laboratory Investigation, 1991